Latest webfg news

Avacta Therapeutics appoints Patrick Vink as deputy chair	08 Jul
Avacta agrees design of pivotal US cancer therapy trial	25 Jun
Avacta flags strong progress across oncology pipeline	22 Jun
Avacta to reduce convertible bond debt after £9m placing	05 Jun
Avacta reports 'encouraging' early signals from AVA6000 clinical data	01 Jun
Avacta strengthens oncology position in 2025	19 May
Avacta shares rise on presentation of new preCISION data	21 Apr
Avacta meets 'important' first-quarter milestones	09 Apr
Avacta doses first patient in phase one AVA6103 trial	31 Mar
Avacta opens phase one clinical trial of second oncology candidate	16 Mar
Avacta upbeat on preCISION comparative study	24 Feb
Avacta finds new science chief internally	09 Feb
Avacta agrees two key clinical trial updates	03 Feb
Avacta to start trialling second drug after FDA clearance	21 Jan
Avacta reports strong operational progress	20 Jan
Avacta upbeat on fresh data from second oncology asset	18 Dec
Avacta reports 'clinically meaningful' tumour shrinkage in AVA6000 trial	17 Dec
Avacta presents promising findings to Boston conference	27 Oct
Avacta raises £16m, releases solid clinical trial data	20 Oct